Willing to begin contraceptive use with either oral contraceptives or Depo-Provera. Nonnucleoside reverse transcriptase inhibitors. Approximately 3 months. Investigator determines that further participation would be detrimental to the patient's health or well-being. Patient fails to comply with study requirements so as to cause harm to self or seriously interfere with the validity of the study results.
Patient requires treatment with medications that are disallowed while on the study.
Patient requires ZDV dose modification during either of the ZDV steady state periods. Always watch for outdated information. This information is designed to support, not replace, the relationship that exists between you and your doctor.